Healthcare -
Biotechnology - NASDAQ - US
$ 11.535
-1.49 %
$ 467 M
Market Cap
-2.21
P/E
KROS - COMMON STOCK REPURCHASED
Common Stock Repurchased KROS - Keros Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR